Emerging technologies open new horizons in glaucoma structural evaluation, management
Michael H. Davidson, MD, discusses PCSK9 as a target of therapy
Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes
Maintenance pazopanib extended PFS, not OS in ovarian cancer
Journal of Psychosocial Nursing and Mental Health Services
Because SLACK Incorporated reports on emerging technologies, techniques and medical therapies, some print and online reports may discuss drug and device applications that either are not approved by regulatory agencies or are not considered to be within the standard practice of medicine.
Articles are intended for informational purposes only and should not be used as the basis of patient treatment. All opinions expressed by authors and quoted sources are their own and do not necessarily reflect the opinions of the editors, publishers or editorial boards of SLACK Incorporated. The acceptance of advertising in no way implies endorsement by the editors, publishers or editorial boards of SLACK Incorporated.
©2014 All Rights Reserved.